Depression Programming
Revolutionizing Depression Treatment
Explore our innovative programming for treatment-resistant depression, featuring the transformative power of Transcranial Magnetic Stimulation (TMS) and Spravato.
Transcranial Magnetic Stimulation (TMS)
We have crafted specialized programming to address the needs of individuals grappling with treatment-resistant depression (TRD). Our approach includes the utilization of Transcranial Magnetic Stimulation (TMS), a therapeutic technique involving a series of repetitive, brief, and highly focused magnetic pulses designed to stimulate specific brain cells. TMS stands out as an effective and non-invasive treatment option, offering hope for those facing TRD. Notably, this method boasts few known side effects, contributing to its appeal as a promising avenue for individuals seeking relief from the challenges of treatment-resistant depression.
Spravato
Spravato is a prescribed medication employed in tandem with an orally administered antidepressant for the treatment of individuals with treatment-resistant depression. To qualify for Spravato, individuals are required to have undergone trials with four different antidepressant medications before commencing Spravato treatment. Eligibility for Spravato extends to individuals diagnosed with Major Depressive Disorder, ensuring that the therapy is targeted towards those with specific mental health conditions. This comprehensive approach underscores the commitment to addressing treatment-resistant depression through a carefully structured and individualized treatment protocol.
Depression Programming Resources
